Novel heterotypic cell cultures for liver toxicology studies
Novel heterotypic cell cultures for liver toxicology studies
批准号:
8323544
负责人:
Alexander Revzin
金额:
$18.29万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2014-07-31
关键词:
AdhesivesAdverse effectsAffectAlcohol consumptionAlcoholsAttentionBMP7 geneCaliberCell Culture SystemCell Culture TechniquesCellsCoculture TechniquesCollagenComplexDevelopmentDrug Metabolic DetoxicationExtracellular MatrixGoalsGrowth FactorHepaticHepatocyteHepatocyte Growth FactorHuman bodyIn VitroInjuryLeadLiverLiver DysfunctionLiver FibrosisLocationMediatingMetabolicMono-SPhenotypePlayPositioning AttributePrincipal InvestigatorPrintingProcessProductionRattusRoleSignal TransductionSignaling MoleculeSpottingsTechnologyTestingTimeLineToxicologyTransforming Growth FactorsTranslatingalcohol effectalcohol exposureautocrinecell typehigh throughput screeningimprintimprovedin vivo Modelnovelparacrinepreventprogramsreceptorresearch studyresponsestellate celltherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of our proposal is to investigate paracrine fibrogenic signaling between parenchymal and non parenchymal liver cells during alcohol injury. Whereas the nonparenchymalcompartment (stellate cells) remains the major player in the development of liver, the role of the parenchymal cells (hepatocytes) in this process is drawing increasing attention. Improved understanding of the roles played by parenchymal and nonparenchymalliver cells during alcohol insult will translate into better, more effective and targeted therapeutics. However, the complex signaling exchange between different liver cell types is difficult to delineate with in vivo models or standard in vitro cell culture approaches. In this proposal, we will utilize a novel liver cell culture approach to investigate !he hypothesis that hepatic production of transforming growth factor (TGF)-¿ plays an important role in initiating the fibrogneic program of stellate cells. This hypothesis will be explored using a novel cell culture system where cell adhesive and/or signaling molecules are imprinted into a culture substrate so as to position discrete groups of hepatocytes and stellate cells in defined locations and in close proximity to each other (see Figure 1 (A,B)). As shown in Figure 1 C, this novel cell culture dish will be used to selectively stimulate hepatocytes within the co-cultures with anti-fibrotic growth factors (GFs) (e.g. HGF and BMP7) during alcohol injury in order to investigate how GF signals delivered to hepatocytes impact activation of neighboring stellate cells. The novelty of the proposed platform lies in our ability to define interactions of two liver cell types cultured in the same dish so as to modulate the phenotype of one cell type and to study the response of the other cell type. This approach is particularly well-suited for improving our understanding of the complex heterotypic signaling underlying liver fibrosis. The novel cell culture system described here is envisioned as an enabling technology for liver toxicology studies and for high-throughput screening of liver-protective molecules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases
-
批准号:10736006
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2023
-
负责人:Alexander Revzin
-
依托单位:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
-
批准号:9882916
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2020
-
负责人:Alexander Revzin
-
依托单位:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
-
批准号:10155447
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2020
-
负责人:Alexander Revzin
-
依托单位:
Context rich mass spectrometry of molecular localization and cellular interactions
-
批准号:9751908
-
项目类别:
-
资助金额:$47.88万
-
财政年份:2017
-
负责人:Alexander Revzin
-
依托单位:
Microsystems for Shaping Stem Cell Fate Selections
-
批准号:9215666
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2016
-
负责人:Alexander Revzin
-
依托单位:
Microsystems for Shaping Stem Cell Fate Selections
-
批准号:9889953
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2016
-
负责人:Alexander Revzin
-
依托单位:
Microsystems for Shaping Stem Cell Fate Selections
-
批准号:9412328
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2016
-
负责人:Alexander Revzin
-
依托单位:
Novel heterotypic cell cultures for liver toxicology studies
-
批准号:8054693
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2011
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8448619
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8066334
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8247791
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8637982
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:7890296
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Microfabricated Biosensor Platform for Monitoring of Cell Metabolism
-
批准号:7471344
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2009
-
负责人:Alexander Revzin
-
依托单位:
Microfabricated Biosensor Platform for Monitoring of Cell Metabolism
-
批准号:7837694
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2009
-
负责人:Alexander Revzin
-
依托单位:
Microfabrication Tools for In Vitro Monitoring of Cancer Cell Metabolism
-
批准号:7366975
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2008
-
负责人:Alexander Revzin
-
依托单位:
Microfabrication Tools for In Vitro Monitoring of Cancer Cell Metabolism
-
批准号:7623951
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2008
-
负责人:Alexander Revzin
-
依托单位:
Effects of Microengineered Interactions on Liver-Specific Gene Expression
-
批准号:7150237
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2006
-
负责人:Alexander Revzin
-
依托单位:
Effects of Microengineered Interactions on Liver-Specific Gene Expression
-
批准号:7273888
-
项目类别:
-
资助金额:$17.95万
-
财政年份:2006
-
负责人:Alexander Revzin
-
依托单位:
海外基金